NICE guideline on Parkinson’s disease

RE: NICE guideline on Parkinson’s disease

The publication date of the Parkinson’s disease (update) guideline has been revised and the guidance is now scheduled to publish mid-June 2017.

If you have any further queries, please contact Jill Peacock at Guideline Coordinator

Dont forget to comment NICE Parkinson’s Quality Standard

Topic engagement on the NICE Parkinson’s disease quality standard is now open

The topic engagement exercise on the Parkinson’s disease quality standard opened 5 days ago. The topic overview published describes core elements of the quality standard and NICE are inviting you to share what you consider to be the 5 key areas for quality improvement in this area.

Please note this is not a consultation on the draft quality standard; there will be a consultation on the draft quality standard on 2 August 2017.

To submit your suggested 5 key areas for quality improvement please visit the topic webpage:

Topic page

NICE encourages you to register as a stakeholder. Comments received from non-registered organisations and individuals are not summarised in the briefing paper presented to the committee but are included as an appendix. These comments are not made available on the NICE website. However, if they result in changes to the quality standard this is recorded in the committee meeting minutes.

Responses must be submitted to by 5pm on 20 April 2017.


Parkinson’s – it’s in the genes

Scientists the Parkinson’s UK fund have discovered changes in 3 genes that may affect brain function – including memory and thinking – in people with early Parkinson’s.

The discovery, in the journal Brain, has been made by researchers in Cambridge and Newcastle as part of a 5 year long study of Parkinson’s dementia funded by Parkinson’s UK.

Over 200 people with and without Parkinson’s took part in the study that investigated if differences in genes commonly seen in people with Parkinson’s were linked to changes in how the brain works.